Napredna pretraga

Pregled bibliografske jedinice broj: 665992

BMP6 mechanism of action in the osteoporosis model of ovariectomized rats


Pećina M, Brkljačić J, Pauk M, Vukičević S.
BMP6 mechanism of action in the osteoporosis model of ovariectomized rats // Combined 33rd SICOT and 17th PAOA Orthopaedic World Conference
Dubai, UAE, 2012. (poster, međunarodna recenzija, sažetak, ostalo)


Naslov
BMP6 mechanism of action in the osteoporosis model of ovariectomized rats

Autori
Pećina M, Brkljačić J, Pauk M, Vukičević S.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Skup
Combined 33rd SICOT and 17th PAOA Orthopaedic World Conference

Mjesto i datum
Dubai, UAE, 28-30.11.2012

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
BMP6; osteoporosis

Sažetak
Osteoporosis is a rare, but serious complication of the long-term heparin therapy. Around one third of patients receiving heparin have a reduction in bone density. In plasma, heparin binds to a number of different proteins, including circulating bone morphogenetic proteins (BMPs). BMP6 has a major role in promoting osteoblast differentiation and bone formation. Here we explored the role of exogenous heparin in BMP6 signaling. We treated C2C12- BRE-Luc cells with combination of BMP6 and heparin for different time points. By western blot and luciferase reporter assay, we show that BMP6-induced Smad1/5/8 phosphorylation was inhibited with heparin. BMP6 is known to induce C2C12 myoblast differentiation toward osteoblast phenotype. We incubated the cells with BMP6 with or without heparin for 24, 48 and 72 hours and measured the expression of early osteoblast markers, alkaline phosphatase (ALP) and osteocalcin (OC). After 48 and 72 hours of treatment, heparin statistically inhibited BMP6-induced ALP and OC gene expression. By using the ectopic bone formation assay in rats, we explored the effect of exogenous heparin on the BMP6-mediated osteogenic activity. We implanted heparin together with BMP6 on demineralized bone matrix (DBM) implants. Two weeks later, we could observe that implants containing the highest dose of heparin morphologically appeared smaller. We also show that BMP6 specifically binds to heparin. We incubated BMP6 with the heparin sepharose beads and BMP6 bound to the beads was detected. Altogether, we suggest that heparin-induced osteoporosis is a consequence, at least in part, of the heparin binding to circulating BMP6.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekt / tema
108-0000000-3652 - Genska terapija mineraliziranih tkiva (Marko Pećina, )

Ustanove
Medicinski fakultet, Zagreb